(Q51371230)

4 April 2018

title

Clinical experience with a simple algorithm for plerixafor utilization in autologous stem cell mobilization. (English)

1 reference

4 April 2018

author

Cedar J. Fowler

7

1 reference

4 April 2018

author name string

A I Chen

1

1 reference

4 April 2018

T Bains

2

1 reference

4 April 2018

S Murray

3

1 reference

4 April 2018

R Knight

4

1 reference

4 April 2018

K Shoop

5

1 reference

4 April 2018

J Bubalo

6

1 reference

4 April 2018

S Slater

8

1 reference

4 April 2018

R T Maziarz

9

1 reference

4 April 2018

language of work or name

English

0 references

publication date

7 May 2012

1 reference

4 April 2018

Bone Marrow Transplantation

published in

1 reference

4 April 2018

volume

47

1 reference

4 April 2018

issue

12

1 reference

4 April 2018

page(s)

1526-1529

1 reference

4 April 2018

Impact of mobilization and remobilization strategies on achieving sufficient stem cell yields for autologous transplantation.

cites work

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.74

Impact of lenalidomide therapy on stem cell mobilization and engraftment post-peripheral blood stem cell transplantation in patients with newly diagnosed myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.74

Phase III prospective randomized double-blind placebo-controlled trial of plerixafor plus granulocyte colony-stimulating factor compared with placebo plus granulocyte colony-stimulating factor for autologous stem-cell mobilization and transplantatio

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.74

Development and validation of a decision-making algorithm to guide the use of plerixafor for autologous hematopoietic stem cell mobilization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.74

Cost and Clinical Analysis of Autologous Hematopoietic Stem Cell Mobilization with G-CSF and Plerixafor Compared to G-CSF and Cyclophosphamide

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.74

Clinical impact and resource utilization after stem cell mobilization failure in patients with multiple myeloma and lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.74

7 January 2021

Factors that influence collection and engraftment of autologous peripheral-blood stem cells

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.74

7 January 2021

Plerixafor and G-CSF versus placebo and G-CSF to mobilize hematopoietic stem cells for autologous stem cell transplantation in patients with multiple myeloma

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.74

7 January 2021

Predicting hematopoietic stem cell mobilization failure in patients with multiple myeloma: a simple method using day 1 CD34+ cell yield

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.74

7 January 2021

Effectiveness and cost analysis of "just-in-time" salvage plerixafor administration in autologous transplant patients with poor stem cell mobilization kinetics

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.74

7 January 2021

Identifiers

DOI

10.1038/BMT.2012.74

1 reference

4 April 2018

1 reference

4 April 2018